Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.
- NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_assertion description "[Although treatment with gefitinib, a tyrosine kinase inhibitor of epidermal growth factor (EGF) receptor, has been reported to be highly effective against lung cancers harboring a mutated EGF gene, its effect against carcinomatous meningitis is unknown.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.
- NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_assertion evidence source_evidence_literature NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.
- NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_assertion SIO_000772 18441512 NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.
- NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_assertion wasDerivedFrom befree-2016 NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.
- NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_assertion wasGeneratedBy ECO_0000203 NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.
- befree-2016 importedOn "2016-02-19" NP668231.RAUAUyGwAEvG3qRzBnggMd9GivKw2VXmdKLba7BxS8k3s130_provenance.